Back to search
FDAFDA · Food and drugs·Recall number D-0731-2023

heparin added to 0.9% sodium chloride, 4,000 units/1,000 mL* (4 units/mL), 1,000 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-7022-1.

Published May 31, 2023 · Recall initiated: April 28, 2023

Summary

FDA records drug Class II recall D-0731-2023, published May 31, 2023 and initiated April 28, 2023. Recalling firm: Central Admixture Pharmacy Services, Inc.; Status: Terminated; Reported quantity: 11117 bags; Lot: Lot # 37-888633, 37-888637, 37-888641, 37-888658, 37-888666, 37-888839, Exp 05/02/2023; 37-890332, 37-890383, 37-890394, 37-890424, 37-890428, 37-890442, Exp 05/09/2023; 37-892010, 37-892021, 37-892046, 37-892061, 37-892116, 37-892120, 37-892150, 37-892153, Exp 05/16/2023; 37-893467, 37-893469, 37-893470, 37-893471, 37-893508, 37-893512, 37-893519, Exp 05/22/2023; 37-893925, 37-893937, 37-893939, 37-893940, 37-893958, 37-893968, Exp 05/23/2023; 37-895218, 37-895220, 37-895224, 37-895231, 37-895236, 37-895305, 37-895306, Exp 05/29/2023; 37-895754, 37-895756, 37-895757, Exp 05/30/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Central Admixture Pharmacy Services, Inc.
Distributor
Nationwide in the USA.
Lot
Lot # 37-888633, 37-888637, 37-888641, 37-888658, 37-888666, 37-888839, Exp 05/02/2023; 37-890332, 37-890383, 37-890394, 37-890424, 37-890428, 37-890442, Exp 05/09/2023; 37-892010, 37-892021, 37-892046, 37-892061, 37-892116, 37-892120, 37-892150, 37-892153, Exp 05/16/2023; 37-893467, 37-893469, 37-893470, 37-893471, 37-893508, 37-893512, 37-893519, Exp 05/22/2023; 37-893925, 37-893937, 37-893939, 37-893940, 37-893958, 37-893968, Exp 05/23/2023; 37-895218, 37-895220, 37-895224, 37-895231, 37-895236, 37-895305, 37-895306, Exp 05/29/2023; 37-895754, 37-895756, 37-895757, Exp 05/30/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was heparin added to 0.9% sodium chloride, 4,000 units/1,000 mL* (4 units/mL), 1,000 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-7022-1. recalled?

Yes. FDA published recall D-0731-2023 on May 31, 2023. Reported hazard: Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail